(13263834), K. H., (5506013), F. X., (586649), L. X., & (2826512), Y. L. (2025). Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.
Chicago Style (17. basım) Atıf(13263834), Kaixiang He, Fujiang Xu (5506013), Li Xiang (586649), ve Yuhao Luo (2826512). Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
MLA (9th ed.) Atıf(13263834), Kaixiang He, et al. Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..